Morepen Laboratories Reports Declining Financial Performance Amid Operational Challenges in June 2025

Morepen Laboratories has recently reported its financial results for the quarter ending June 2025, revealing significant challenges within its operations. The company's score has undergone an adjustment in evaluation, reflecting a shift from -10 to -23 over the past three months. The financial data indicates that Profit Before Tax less Other Income (PBT) has reached Rs 11.11 crore, marking a notable decline compared to the average of Rs 34.19 crore from the previous four quarters. Similarly, Profit After Tax (PAT) stands at Rs 10.75 crore, which is substantially lower than the average PAT of Rs 29.51 crore for the same period. Net sales have also shown a downward trend, recorded at Rs 425.24 crore, the lowest in the last five quarters, and down from an average of Rs 452.90 crore. Operating profit has decreased to Rs 24.18 crore, with the operating profit margin dropping to 5.69%, indicating a decline in the company's efficiency. Additionally, earnings per share (EPS) have fallen to Rs 0.20, reflecting reduced profitability for shareholders. These results highlight the ongoing difficulties faced by Morepen Laboratories in the current market environment. Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.